Jeff Caravella
Keine laufenden Positionen mehr
Vermögen: - $ am 30.04.2024
Profil
Jeff Caravella served as the Chief Financial Officer at BioTheryX, Inc. and Medicenna Therapeutics Corp.
He received an undergraduate degree and an MBA from Syracuse University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.09.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Ehemalige bekannte Positionen von Jeff Caravella
| Unternehmen | Position | Ende |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Finanzdirektor/CFO | 26.10.2023 |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Finanzdirektor/CFO | - |
Ausbildung von Jeff Caravella
| Syracuse University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MEDICENNA THERAPEUTICS CORP. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
